FullHope Biomedical Co.,Ltd. (TPEX:7773)

Market Cap	1.10B -36.4%
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	39.91M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	119,204
Average Volume	55,777
Open	21.50
Previous Close	21.00
Day's Range	21.40 - 27.60
52-Week Range	19.90 - 49.80
Beta	n/a
RSI	59.80
Earnings Date	n/a

About FullHope Biomedical

FullHope Biomedical Co.,Ltd. engages in the research and development of immune system-related services. It develops FHCT001 and FHCT003, an immune cell therapies for cancer; and FHCT002, an auto-immune cell therapy, as well as diagnostic tools. The company also provides various services, including immunoprofiling, circulating tumor cells testing, regulation of cell therapy, contracting immune cell manufacturing, immune cell bank, contract research organization, and endotoxin and mycoplasma detection. FullHope Biomedical Co.,Ltd. was founded in ...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2012
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 7773